Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson’s Disease via Oral Gavage

[Image: see text] Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopamine (DA) neurons in the midbrain substantia nigra pars compacta (SNpc). While existing therapeutic strategies can alleviate PD symptoms, they cannot inhibit DA neuron loss. Herein, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kai, Huang, Peng, Wu, Yixuan, Liu, Teng, Shao, Ningyi, Zhao, Lulu, Hu, Xiaoyan, Chang, Junlei, Peng, Yongbo, Qu, Shaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604087/
https://www.ncbi.nlm.nih.gov/pubmed/37807265
http://dx.doi.org/10.1021/acsnano.3c05011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604087/
https://www.ncbi.nlm.nih.gov/pubmed/37807265
http://dx.doi.org/10.1021/acsnano.3c05011

Ejemplares similares